Project cooperationUpdated on 21 January 2026
Trustworthy AI development partner
Research Scientist at Fraunhofer IKS
Munich, Germany
About
The trustworthy digital health group at Fraunhofer IKS researches and develops AI applications for the healthcare industry, prioritizing trustworthiness, explainability, and robustness.
The group is looking to join a consortium to as an AI development partner for prediction and/or decision support applications in the areas of cardiology and/or women's health.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Trustworthy AI development partner
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
Katherine Fitch
Head of Department - Trustworthy Digital Health at Fraunhofer IKS
Munich, Germany
Project cooperation
AI-enabled personalised care pathways for preventive and precision medicine
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
Bruno Pires
Managing Partner at Here Partners
Lisbon, Portugal
Project cooperation
Cardiovascular disease, imaging, biomarkers, diagnosis and risk stratification, AI
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
Gudrun Feuchtner
Professor, Cardiovascular Imaging, MD, MBA at Innsbruck Medical University
Innsbruck, Austria